• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Inovalon & AWS to Develop AI/ML Solutions for Healthcare

Share:

October 21, 2023

Amazon Web Services (AWS) and Inovalon have joined forces to develop AI and ML-driven solutions for healthcare organizations, aiming to enhance patient outcomes and cost-efficiency. These solutions, part of the Inovalon ONE® Platform, initially target risk adjustment with a focus on improving risk score accuracy for health plans using natural language processing (NLP) tools. By combining AWS’s Comprehend Medical® NLP service with Inovalon’s AI/ML capabilities, the collaboration intends to identify discrepancies between clinical documentation and claims data, offering insights and enriched patient data to streamline claim reviews and reduce costs. The application is expected to launch in early 2024, marking the start of several collaborations between Inovalon and AWS to improve healthcare outcomes.

Amazon Web Services and Inovalon announced a collaboration to develop AI and ML-based solutions for healthcare organizations to improve patient outcomes and cost-savings.

The collaborated capabilities are being developed for multiple applications across the broader Inovalon ONE® Platform, the Company’s SaaS-based software platform supporting more than 20,000 customer organizations across the healthcare ecosystem. The initial offerings will focus on risk adjustment, with a particular emphasis on developing natural language processing (NLP) tools to improve risk score accuracy for health plans.

Advanced AI/ML Together with Large Training Datasets

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Health plans primarily depend upon medical documentation and medical claims to determine the disease burden, or risk score, of the members of their managed populations. This risk score is then utilized to inform the application of appropriate resources to support members’ health care needs as well as accurate payments and reimbursements. Unfortunately, meaningful disconnects exist between medical documentation and claims data resulting in an incomplete understanding of patient disease status, progression, and care needs, as well as inaccurate payments and reimbursements. As a result, health plans expend significant resources to more accurately understand and substantiate their members’ risk scores.

While Natural Language Processing (NLP) technologies have been applied within the healthcare industry to aid in the capture and analysis of risk score information, the industry’s currently available NLP solutions struggle to tease out key data points from the medical records without an extremely high false positive rate. Further, today’s solutions fail to provide meaningful targeting insight to guide a clinician, medical record reviewer, or auditor to precisely where an area of concern within a patient’s case documentation may lie. The net result is lower accuracy within risk scores, lower understanding of individual patient’s disease status and care needs, higher costs related to accuracy-improving initiatives, and greater risk to health plans concerning their inadvertent submission of inaccurate risk score data which can lead to potential legal liability and financial penalties.

The NLP/ML-powered application being developed collaboratively by Inovalon leverages AWS’s Amazon Comprehend Medical® NLP service to derive insights from unstructured clinical text and map clinical concepts to standardized medical codes like ICD10-CM. The enriched output from Comprehend Medical is combined with a logical scaffolding created from Inovalon’s AI/ML capabilities and deep subject matter expertise. The result is an advanced capability to analyze targeted member medical records to identify those that are highly likely to have meaningful disconnects between the clinical documentation and that of the claims data associated with the patient. Additionally, the solution not only determines the probability of such disconnects being statistically true positives but also highlights where the evidence that supports a concern resides. The result is a solution that empowers users with powerful insights and enriched patient-level data with greater risk score accuracy to augment claim review efficiency and decrease costs. Inovalon expects the application to be generally available early in 2024.

“Our focus is on the relentless enhancement of the Inovalon ONE Platform so that we can in turn empower our customers to achieve their missions,” said Eron Kelly, President of Inovalon. “This is the first of several collaborations we are doing with AWS to empower our customers to improve healthcare outcomes and economics through the thoughtful and careful use of AI/ML.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • USC Norris launches study to increase diversity among clinical trial participantsUSC Norris launches study to increase diversity among clinical trial participants
  • PicnicHealth Partners with AstraZeneca to Advance Cancer Datasets.PicnicHealth Partners with AstraZeneca to Advance Cancer Datasets.
  • Eroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged CompanyEroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Company
  • Women’s Health Company Kindbody Scores New Funding from GVWomen’s Health Company Kindbody Scores New Funding from GV
  • X4 Pharmaceuticals Completes Merger with ArsanisX4 Pharmaceuticals Completes Merger with Arsanis
  • Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to Its Business and Become Industry Leader in Psychedelic Enhanced PsychotherapyOptimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to Its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
  • Diabetes Management Startup Glooko Collects $30M to Push Remote Monitoring, New Therapy AreasDiabetes Management Startup Glooko Collects $30M to Push Remote Monitoring, New Therapy Areas
  • RA Capital Closes $461 Million Investment Fund Aimed at Life Sciences CompaniesRA Capital Closes $461 Million Investment Fund Aimed at Life Sciences Companies

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications